Curology, a San Diego and San Francisco, CA-based dermatologist-founded direct-to-consumer prescription skincare company, completed a $15m Series B financing.
The round was led by Advance Vixeid Partners, with participation from prior investors Sherpa Capital and Forerunner Ventures.
The company intends to use the funds to hire visual designers and marketing experts and expand operations.
Led by founder and CEO David Lortscher, MD, Curology is a prescription skincare company, specializing in acne and anti-aging treatments. The company’s online solution enables patients to remotely share photos of their skin with a licensed medical professional, who after an initial consultation, prescribes patients a customized topical medication designed for their specific skin needs.